Are Gastrointestinal Cancers Increasing Among Middle-Aged Adults Globally?

Synopsis
Key Takeaways
- GI cancers are increasingly prevalent in adults under 50.
- Colorectal cancer is the most common early-onset GI cancer.
- Other rising cancers include gastric, oesophageal, and pancreatic.
- Modifiable lifestyle factors significantly impact cancer risk.
- Early detection and screening are critical for better outcomes.
New Delhi, July 18 (NationPress) Gastrointestinal (GI) cancers are experiencing a concerning rise globally among individuals under 50 years of age, as highlighted by two significant studies.
The first study, featured in JAMA, indicates that the increase in cancer cases extends beyond colorectal cancer, encompassing gastric, oesophageal, and pancreatic types.
"While colorectal cancer remains the most prevalent early-onset GI cancer globally, representing over half of the cases, it is not the sole type witnessing a surge among younger adults. Sadly, pancreatic, gastric, and oesophageal cancers are also on the rise in this demographic," stated Dr. Kimmie Ng from Dana-Farber Cancer Institute in the US.
"The escalating incidence of early-onset GI cancers is troubling and emphasizes the urgent need for improved prevention strategies and early detection techniques," Ng added.
The second study, published in the British Journal of Surgery, revealed a 14.8 percent increase in newly diagnosed cases of early-onset GI cancers from 2010 to 2019.
The research highlighted that the number of early-onset GI cancer cases is highest among individuals aged 40 to 49, but the growth rate is significantly sharper among younger cohorts.
Findings indicated that individuals born in 1990 are twice as likely to develop colon cancer and four times more likely to face rectal cancer compared to those born in 1950, with Ng leading the research.
Common modifiable risk factors associated with early-onset GI cancers include obesity, unhealthy diets, sedentary lifestyles, smoking, and alcohol consumption.
The study also stresses the significance of genetic testing for all patients diagnosed with early-onset GI cancers to evaluate familial cancer risks and inform treatment plans, in addition to promoting early screening.
"Adherence to screening is absolutely vital. Each overlooked screening is a missed chance to catch cancer early while it remains more treatable or to avert the disease by identifying and removing precancerous polyps," remarked Dr. Thejus Jayakrishnan from Dana-Farber.